Cord Blood America CEO Discusses Company Strategy in Interview
Specifically the Company's growth strategy was discussed and Mr. Schissler stated that Cord Blood America would grow organically, through acquisitions and diversification of income streams.
The interview is available at http://inboundmarketingpr.com/clients/cord-blood-america/bid/39713/Cord-Blood-America-Interview-with-Matt-Schissler-CEO
About Cord Blood America
Cord Blood America (OTC Bulletin Board:CBAI.ob - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board:CBAI.ob).
-- Cord Blood America is growing organically through relationships with insurance companies such as Blue Cross. -- The Company's acquisition strategy, which is aggressive, will continue through the rest of 2010 and into 2011. Current and pending acquisitions will increase Cord Blood America's revenue 40-50 percent during 2010. -- Diversification of income streams via placenta collection services which are already providing income with one agreement in place.
SOURCE Cord Blood America, Inc.
You May Also Like